06.12.2016
SOCIUM awarded Research Funding from German Innovation Fund

SOCIUM awarded Research Funding from German Innovation Fund

Grant Awarded for Project on the Needs-Based Provision of Medical Care to Nursing Home Residents.

This year, the German Innovation Funds has provided research funding to the tune of € 300m. Of that money, € 225m. have been awarded for the implementation of new healthcare models, and €75m. for research on health services research. Around 600 applications for research funding were submitted; 62, that is one in ten, projects were approved. One of the grants was awarded to SOCIUM. The primary aim of the project submitted by Professor Rothgang (SOCIUM) and his team is to gain a better knowledge of needs-based medical care by general practitioners and medical specialists to nursing home residents with a view to improving the needs-based provision of medical care in that setting. Read more ...

01.12.2016
Research and learning really combined

Research and learning really combined

Berninghausen Prize for excellent teaching awarded to Heinz Rothgang.

Often the daily routines of university campus life fall short of the Humboldtian ideal of an interdependence between excellent research and excellent teaching. Too many students, too much expense, too little time - there are enough reasons why even at universities students are experiencing too much teacher-centred teaching. With their concept for a three-semester long research/teaching project in the Master of Public Health Programme, Heinz Rothgang and Ansgar Gerhardus have succeeded in changing that. The Master in Public Health is intricately related to practice and interdisciplinary as well, but presupposes a profound knowledge of theories and methodology. Since many students have practical experience and are headed back to practice the research part of their Master often falls short of expectations. Read more ...

07.09.2016
Innovation Report 2016 Published

Innovation Report 2016 Published

The Evaluation of Pharmaceutical Products Introduced in 2013 and The Pharmaceutical Market Restructuring Act (AMNOG) Five Years on.

The present innovation report, edited by Gerd Glaeske, Petra Thürmann and Wolf-Dieter Ludwig now appears for the fourth time since 2013. It focuses on 23 drugs, which were introduced to the German market in 2013. Firstly, with respect to their therapeutic benefits according to the criteria of evidence based medicine, on the other hand with regard to their market development and supply reality in the years 2013 and 2014 on the basis of routine data from the Techniker Krankenkasse. Read more ...